melanoma

FDA approves new melanoma treatments

On Oct. 28, the U.S. Food and Drug Administration (FDA) expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with…

Making a stand against malignant melanoma

Summer sizzles on, sun-worshipers soak up the rays. Years later, your ability to detect melanoma in its early stages could spell the difference between a patient’s prompt treatment…
melanoma risk factors kidney transplants

Melanoma risk factors after kidney transplant

Melanoma risk factors for patients who have undergone kidney transplant include being older, white, and male, according to a study in JAMA Dermatology. Read more 

Mitigating melanoma

Early detection and intervention is key for higher survival rates. Takeaways: Late identification and recognition of melanoma lead to worsening health outcomes. Nursing patient education requires that nurses…

Study: Melanoma increases among middle-aged adults

A study in Mayo Clinic Proceedings reports that the incidence of cutaneous melanoma among middle-aged adults (40 to 60 years) has increased nearly eightfold between 1970 and 2009,…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

Poll

Preferred way to get content

What is your preferred way to consume healthcare content?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.